The Management of Peyronie's Disease: Evidence-based 2010 Guidelines

Lue, 2004, Summary of the recommendations on sexual dysfunctions in men, J Sex Med, 1, 6, 10.1111/j.1743-6109.2004.10104.x Schwarzer, 2001, The prevalence of Peyronie's disease: Results of a large survey, BJU Int, 88, 727, 10.1046/j.1464-4096.2001.02436.x Deveci, 2007, Defining the clinical characteristics of peyronie's disease in young men, J Sex Med, 4, 485, 10.1111/j.1743-6109.2006.00344.x Kendirci, 2007, Diabetes mellitus is associated with severe Peyronie's disease, BJU Int, 99, 383, 10.1111/j.1464-410X.2007.06611.x Kadioglu, 2002, A retrospective review of 307 men with Peyronie's disease, J Urol, 68, 1075 Mulhall, 2006, An analysis of the natural history of Peyronie's disease, J Urol, 175, 2115, 10.1016/S0022-5347(06)00270-9 Levine, 2003, Establishing a standardized evaluation of the man with Peyronie's disease, Int J Impot Res, 15, S103, 10.1038/sj.ijir.3901083 Pryor, 2004, Peyronie's disease, J Sex Med, 1, 110, 10.1111/j.1743-6109.2004.10116.x Pryor, 2002, Clinical presentations of Peyronie's disease, Int J Impot Res, 14, 414, 10.1038/sj.ijir.3900877 Bella, 2007, Nonpalpable scarring of the penile septum as a cause of erectile dysfunction: An atypical form of Peyronie's disease, J Sex Med, 4, 226, 10.1111/j.1743-6109.2006.00316.x Vernet, 2005, Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells: Implications for peyronie disease, Biol Reprod, 73, 1199, 10.1095/biolreprod.105.041038 Ohebshalom, 2007, Measurement of penile curvature in Peyronie's disease patients: Comparison of three methods, J Sex Med, 4, 199, 10.1111/j.1743-6109.2006.00404.x Rosen, 2008, Impact of Peyronie's disease on sexual and psychosocial functioning: Qualitative findings in patients and controls, J Sex Med, 5, 1977, 10.1111/j.1743-6109.2008.00883.x Smith, 2008, Risk factors for emotional and relationship problems in Peyronie's disease, J Sex Med, 5, 2179, 10.1111/j.1743-6109.2008.00949.x Nelson, 2008, The chronology of depression and distress in men with Peyronie's disease, J Sex Med, 5, 1985, 10.1111/j.1743-6109.2008.00895.x Amin, 1993, Colour Doppler and duplex ultrasound assessment of Peyronie's disease in impotent men, B J Rad, 66, 398, 10.1259/0007-1285-66-785-398 Kadioglu, 2004, Incidentally diagnosed Peyronie's disease in men presenting with erectile dysfunction, Int J Impot Res, 16, 540, 10.1038/sj.ijir.3901247 Gasior, 1990, Plaque-associated corporal venoocclusive dysfunction in idiopathic Peyronie's disease: A pharmacocavernosometric and pharmacocavernosographic study, World J Urol, 8, 90, 10.1007/BF01576355 Rosen, 1997, The International Index of Erectile function (IIEF): A multidimensional scale for the assessment of erectile dysfunction, Urology, 49, 822, 10.1016/S0090-4295(97)00238-0 Hauck, 2003, Diagnostic value of magnetic resonance imaging in Peyronie's disease—A comparison both with palpation and ultrasound in the evaluation of plaque formation, Eur Urol, 43, 293, 10.1016/S0302-2838(03)00003-4 Aversa, 2007, The role of penile colorduplex ultrasound for the evaluation of erectile dysfunction, J Sex Med, 4, 1437, 10.1111/j.1743-6109.2007.00546.x Kadioglu, 2000, Color Doppler ultrasound assessment of penile vascular system in men with Peyronie's disease, Int J Impot Res, 12, 263, 10.1038/sj.ijir.3900569 LaRochelle, 2007, A survey of primary care physicians and urologists regarding Peyronie's disease, J Sex Med, 4, 1167, 10.1111/j.1743-6109.2007.00537.x Müller, 2009, Peyronie's disease intervention trials: Methodological challenges and issues, J Sex Med, 6, 848, 10.1111/j.1743-6109.2008.01081.x Smith, 2008, Peyronie's disease: A critical appraisal of current diagnosis and treatment, Int J Impot Res, 20, 445, 10.1038/ijir.2008.30 Bella, 2007, Peyronie's disease (CME), J Sex Med, 4, 1527, 10.1111/j.1743-6109.2007.00614.x Taylor, 2007, Peyronie's disease, Urol Clin North Am, 34, 517, 10.1016/j.ucl.2007.08.017 Greenfield, 2005, Peyronie's disease: Etiology, epidemiology and medical treatment, Urol Clin North Am, 32, 469, 10.1016/j.ucl.2005.08.011 Smith, 2005, Peyronie's disease: The epidemiology, aetiology and clinical evaluation of deformity, BJU Int, 95, 729, 10.1111/j.1464-410X.2005.05391.x Rhoden, 2001, Prevalence of Peyronie's disease in men over 50-year-old from Southern Brazil, Int J Impot Res, 13, 291, 10.1038/sj.ijir.3900727 Mulhall, 2004, Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening, J Urol, 171, 2350, 10.1097/01.ju.0000127744.18878.f1 La Pera, 2000, SIMONA Study Group. Peyronie's disease: Prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50–69 years, Eur Urol, 40, 525, 10.1159/000049830 Kumar, 2006, A clinico-aetiological and ultrasonographic study of Peyronie's disease, Sex Health, 3, 113, 10.1071/SH05031 El-Sakka, 2006, Prevalence of Peyronie's disease among patients with erectile dysfunction, Eur Urol, 49, 564, 10.1016/j.eururo.2005.10.026 Tefekli, 2006, Peyronie's disease: A silent consequence of diabetes mellitus, Asian J Androl, 8, 75, 10.1111/j.1745-7262.2006.00099.x Usta, 2004, Stratification of penile vascular pathologies in patients with Peyronie's disease and in men with erectile dysfunction according to age: A comparative study, J Urol, 172, 259, 10.1097/01.ju.0000132154.38285.c7 Usta, 2004, Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronie's disease, J Urol, 171, 775, 10.1097/01.ju.0000097498.34847.7c El-Sakka, 2005, Peyronie's disease in diabetic patients being screened for erectile dysfunction, J Urol, 174, 1026, 10.1097/01.ju.0000170231.51306.32 Tefekli, 2001, Peyronie's disease in men under age 40: Characteristics and outcome, Int J Impot Res, 13, 18, 10.1038/sj.ijir.3900635 Carrieri, 1998, A case-control study on risk factors for Peyronie's disease, J Clin Epidemiol, 51, 511, 10.1016/S0895-4356(98)00015-8 Perimenis, 2001, Peyronie's disease: Epidemiology and clinical presentation of 134 cases, Int Urol Nephrol, 32, 691, 10.1023/A:1014485204205 Bjekic, 2006, Risk factors for Peyronie's disease: A casecontrol study, BJU Int, 97, 570, 10.1111/j.1464-410X.2006.05969.x Arafa, 2007, The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction, Int J Impot Res, 19, 213, 10.1038/sj.ijir.3901518 Gonzalez-Cadavid, 2009, Experimental models of Peyronie's disease: Implications for new therapies, J Sex Med, 6, 303, 10.1111/j.1743-6109.2008.01104.x Gonzalez-Cadavid, 2007, Experimental models for the study of the cellular and molecular pathophysiology of Peyronie's disease, 19, 10.1007/978-1-59745-161-1_3 Sasso, 2007, Peyronie's disease: Lights and shadows, Urol Int, 78, 1, 10.1159/000096927 Devine, 1997, Proposal: Trauma as the cause of the Peyronie's lesion, J Urol, 157, 285, 10.1016/S0022-5347(01)65361-8 Somers, 1997, Fibrin deposition in Peyronie's disease plaque, J Urol, 157, 311, 10.1016/S0022-5347(01)65367-9 Van de Water, 1997, Mechanisms by which fibrin and fibronectin appear in healing wounds: Implications for Peyronie's disease, J Urol, 157, 306, 10.1016/S0022-5347(01)65366-7 Davila, 2005, Peyronie's disease associated with increase in plasminogen activator inhibitor in fibrotic plaque, Urology, 65, 645, 10.1016/j.urology.2005.01.010 Ehrlich, 1997, Scar contracture: Cellular and connective tissue aspects in Peyronie's disease, J Urol, 157, 316, 10.1016/S0022-5347(01)65368-0 Davila, 2003, Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: A new animal model of Peyronie's disease, BJU Int, 91, 830, 10.1046/j.1464-410X.2003.04224.x Davila, 2004, Gene transfer of inducible nitric oxide synthase complementary DNA regresses the fibrotic plaque in an animal model of Peyronie's disease, Biol Reprod, 71, 1568, 10.1095/biolreprod.104.030833 Zargooshi, 2004, Trauma as the cause of Peyronie's disease: Penile fracture as a model of trauma, J Urol, 172, 186, 10.1097/01.ju.0000132144.71458.86 El-Sakka, 1998, The effect of surgical trauma on rat tunica albuginea, J Urol, 159, 1700, 10.1097/00005392-199805000-00097 Schiavino, 1997, Immunologic findings in Peyronie's disease: A controlled study, Urology, 50, 764, 10.1016/S0090-4295(97)00333-6 Noss, 2000, The genetics and immunology of Peyronie's disease, Int J Impot Res, 12, S127, 10.1038/sj.ijir.3900591 Hauck, 2003, Prospective analysis of HLA classes I and II antigen frequency in patients with Peyronie's disease, J Urol, 170, 1443, 10.1097/01.ju.0000076488.89748.e1 Hauck, 2004, Alpha-1-antitrypsin levels and genetic variation of the alpha-1-antitrypsin gene in Peyronie's disease, Eur Urol, 46, 623, 10.1016/j.eururo.2004.04.028 Hauck, 2003, Prospective analysis of single nucleotide polymorphisms of the transforming growth factor beta-1 gene in Peyronie's disease, J Urol, 169, 369, 10.1016/S0022-5347(05)64129-8 Ralph, 1997, The genetic and bacteriological aspects of Peyronie's disease, J Urol, 157, 291, 10.1016/S0022-5347(01)65362-X Domes, 2007, Is there a role for proteomics in Peyronie's disease?, J Sex Med, 4, 867, 10.1111/j.1743-6109.2007.00470.x Ferrini, 2002, Antifibrotic role of inducible nitric oxide synthase, Nitric Oxide, 6, 283, 10.1006/niox.2001.0421 Iacono, 1994, Microstructural disorders of tunica albuginea in patients affected by impotence, Eur Urol, 26, 233, 10.1159/000475386 Anafarta, 1994, The significance of histopathological changes of the normal tunica albuginea in Peyronie's disease, Int Urol Nephrol, 26, 71, 10.1007/BF02768246 Brock, 1997, The anatomy of the tunica albuginea in the normal penis and Peyronie's disease, J Urol, 157, 276, 10.1016/S0022-5347(01)65359-X Mirone, 2002, A new biopsy technique to investigate Peyronie's disease associated histologic alterations: Results with two different forms of therapy, Eur Urol, 42, 239, 10.1016/S0302-2838(02)00225-7 Somers, 1989, Isolation and characterization of collagen in Peyronie's disease, J Urol, 141, 629, 10.1016/S0022-5347(17)40920-7 Gentile, 1996, Ultrastructural and immunohistochemical characterization of the tunica albuginea in Peyronie's disease and veno-occlusive dysfunction, J Androl, 17, 96 Davis, 1997, The microscopic pathology of Peyronie's disease, J Urol, 157, 282, 10.1016/S0022-5347(01)65360-6 Hirano, 1997, Electron microscopic study of the penile plaques and adjacent corpora cavernosa in Peyronie's disease, Int J Urol, 4, 274, 10.1111/j.1442-2042.1997.tb00188.x Vernet, 2002, Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model, Nitric Oxide, 7, 262, 10.1016/S1089-8603(02)00124-6 Eyden, 2008, The myofibroblast: Phenotypic characterization as a prerequisite to understanding its functions in translational medicine, J Cell Mol Med, 12, 22, 10.1111/j.1582-4934.2007.00213.x Vernet, 2006, Phosphodiesterase type 5 is not upregulated by tadalafil in cultures of human penile cells, J Sex Med, 3, 84, 10.1111/j.1743-6109.2005.00197.x Vande Berg, 1982, Mechanisms of calcification in Peyronie's disease, J Urol, 127, 52, 10.1016/S0022-5347(17)53599-5 El-Sakka, 1997, An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression, J Urol, 158, 2284, 10.1016/S0022-5347(01)68236-3 El-Sakka, 1998, Histological and ultrastructural alterations in an animal model of Peyronie's disease, Br J Urol, 81, 445, 10.1046/j.1464-410x.1998.00529.x El-Sakka, 1999, The effects of colchicine on a Peyronie's-like condition in an animal model, J Urol, 161, 1980, 10.1016/S0022-5347(05)68868-4 Bivalacqua, 2000, A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression, J Urol, 163, 1992, 10.1016/S0022-5347(05)67616-1 Bivalacqua, 2001, Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie's-like condition in the rat, J Androl, 22, 497 Valente, 2003, L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures, Nitric Oxide, 9, 229, 10.1016/j.niox.2003.12.002 Ferrini, 2006, Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease, BJU Int, 97, 625, 10.1111/j.1464-410X.2006.05955.x Cantini, 2008, Profibrotic role of myostatin in Peyronie's disease, J Sex Med, 5, 1607, 10.1111/j.1743-6109.2008.00847.x Wynn, 2008, Cellular and molecular mechanisms of fibrosis, J Pathol, 214, 199, 10.1002/path.2277 Piao, 2008, Repeated intratunical injection of adenovirus expressing transforming growth factor-beta1 in a rat induces penile curvature with tunical fibrotic plaque: A useful model for the study of Peyronie's disease, Int J Androl, 31, 346, 10.1111/j.1365-2605.2007.00780.x Lucattelli, 2008, A new mouse model of Peyronie's disease: An increased expression of hypoxia-induciblefactor-1 target genes during the development of penile changes, Int J Biochem Cell Biol, 40, 2638, 10.1016/j.biocel.2008.05.012 Somers, 1982, Cell culture of Peyronie's disease plaque and normal penile tissue, J Urol, 127, 585, 10.1016/S0022-5347(17)53917-8 Mulhall, 2004, Chromosomal instability is demonstrated by fibroblasts derived from the tunica of men with Peyronie's disease, Int J Impot Res, 16, 288, 10.1038/sj.ijir.3901170 Mulhall, 2001, Perturbation of cell cycle regulators in Peyronie's disease, Int J Impot Res, 13, S21, 10.1038/sj.ijir.3900771 Mulhall, 2001, Basic fibroblast growth factor expression in Peyronie's disease, J Urol, 165, 419, 10.1097/00005392-200102000-00016 Mulhall, 2003, Radiation increases fibrogenic cytokine expression by Peyronie's disease fibroblasts, J Urol, 170, 281, 10.1097/01.ju.0000070860.78370.08 Mulhall, 2002, Peyronie's disease cell culture models: Phenotypic, genotypic and functional analyses, Int J Impot Res, 14, 397, 10.1038/sj.ijir.3900874 Mulhall, 2004, Peyronie's disease fibroblasts demonstrate tumorigenicity in the severe combined immunodeficient (SCID) mouse model, Int J Impot Res, 16, 99, 10.1038/sj.ijir.3901183 Mulhall, 2003, Expanding the paradigm for plaque development in Peyronie's disease, Int J Impot Res, 15, S93, 10.1038/sj.ijir.3901082 Haag, 2008, Investigation of the antifibrotic effect of IFN-gamma on fibroblasts in a cell culture model of Peyronie's disease, Eur Urol, 53, 425, 10.1016/j.eururo.2007.06.036 Hinz, 2007, The myofibroblast: One function, multiple origins, Am J Pathol, 170, 1807, 10.2353/ajpath.2007.070112 Nolazco, 2008, Effect of muscle-derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat, BJU Int, 101, 1156, 10.1111/j.1464-410X.2008.07507.x Gonzalez-Cadavid, 2009, Mechanisms of penile fibrosis, J Sex Med, 6, 353, 10.1111/j.1743-6109.2008.01195.x El-Sakka, 1997, Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression, J Urol, 158, 1391, 10.1016/S0022-5347(01)64223-X Lin, 2002, Upregulation of monocyte chemoattractant protein 1 and effects of transforming growth factor-beta 1 in Peyronie's disease, Biochem Biophys Res Commun, 295, 1014, 10.1016/S0006-291X(02)00765-9 Wang, 2003, Wogonin suppresses cellular proliferation and expression of monocyte chemoattractant protein 1 in Peyronie's plaque-derived cells, BJU Int, 92, 753, 10.1046/j.1464-410X.2003.04464.x Gonzalez-Cadavid, 2005, The pleiotropic effects of inducible nitric oxide synthase on the physiology and pathology of penile erection, Curr Pharm Des, 11, 4041, 10.2174/138161205774913372 Del Carlo, 2008, Differential calcium independent regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by interleukin-1beta and transforming growth factor-beta in Peyronie's plaque fibroblasts, J Urol, 179, 2447, 10.1016/j.juro.2008.01.093 Gelbard, 1993, Collagenase versus placebo in the treatment of Peyronie's disease: A double-blind study, J Urol, 149, 56, 10.1016/S0022-5347(17)35998-0 Gonzalez-Cadavid, 2005, Mechanisms of disease: New insights into the cellular and molecular pathology of Peyronie's disease, Nat Clin Pract Urol, 2, 291, 10.1038/ncpuro0201 Magee, 2002, Gene expression profiles in the Peyronie's disease plaque, Urology, 59, 451, 10.1016/S0090-4295(01)01578-3 Qian, 2004, Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture, Urology, 64, 399, 10.1016/j.urology.2004.04.006 Ferrini, 2007, Longterm continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis, Biol Reprod, 76, 915, 10.1095/biolreprod.106.059642 Kovanecz, 2008, Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction (CVOD) that occurs following cavernosal nerve resection in the rat, BJU Int, 101, 203 Zarafonetis, 1959, Treatment of Peyronie's disease with potassium paraaminobenzoate (Potaba), J Urol, 81, 770, 10.1016/S0022-5347(17)66108-1 Shah, 1983, A multicentre doubleblind controlled clinical trial of potassium-para-aminobenzoate (Potaba) in Peyronie's disease, Prog Reprod Biol Med, 9, 61 Weidner, 2005, Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: A prospective, placebocontrolled, randomized study, Eur Urol, 47, 530, 10.1016/j.eururo.2004.12.022 Shindel, 2008, Urologist practice patterns in the management of Peyronie's disease: A nationwide survey, J Sex Med, 5, 954, 10.1111/j.1743-6109.2007.00674.x Pryor, 1983, Controlled clinical trial of vitamin E in Peyronie's disease, Prog Reprod Biol Med, 9, 41 Safarinejad, 2007, Comparison of vitamin E and propionyl-Lcarnitine, separately or in combination, in patients with early chronic Peyronie's disease: A doubleblind, placebo controlled, randomized study, J Urol, 178, 1398, 10.1016/j.juro.2007.05.162 Ralph, 1992, The treatment of Peyronie's disease with tamoxifen, Br J Urol, 70, 648, 10.1111/j.1464-410X.1992.tb15836.x Teloken, 1999, Tamoxifen versus placebo in the treatment of Peyronie's disease, J Urol, 162, 2003, 10.1016/S0022-5347(05)68087-1 Akkus, 1994, Is colchicine effective in Peyronie's disease? A pilot study, Urology, 44, 291, 10.1016/S0090-4295(94)80155-X Kadioglu, 2000, Treatment of Peyronie's disease with oral colchicine: Long-term results and predictive parameters of successful outcome, Int J Impot Res, 12, 169, 10.1038/sj.ijir.3900519 Safarinejad, 2004, Therapeutic effects of colchicine in the management of Peyronie's disease: A randomized double-blind, placebo-controlled study, Int J Impot Res, 16, 238, 10.1038/sj.ijir.3901185 Prieto Castro, 2003, Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease, BJU Int, 91, 522, 10.1046/j.1464-410X.2003.04134.x Biagiotti, 2001, Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: A preliminary report, BJU Int, 88, 63, 10.1046/j.1464-410x.2001.02241.x Cavallini, 2002, Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease, BJU Int, 89, 895, 10.1046/j.1464-410X.2002.02738.x Brant, 2006, Treatment of Peyronie's disease with oral pentoxifylline, Nat Clin Pract Urol, 3, 111, 10.1038/ncpuro0409 Winter, 1975, Peyronie's disease: Results with dermo-jet injection of dexamethasone, J Urol, 114, 898, 10.1016/S0022-5347(17)67169-6 Desanctis, 1967, Steroid injection therapy for Peyronie's disease: A 10-year summary and review of 38 cases, J Urol, 97, 114, 10.1016/S0022-5347(17)62993-8 Teasley, 1954, Peyronie's disease: A new approach, J Urol, 71, 611, 10.1016/S0022-5347(17)67832-7 Williams, 1980, The non-surgical treatment of Peyronie's disease, Br J Urol, 52, 392, 10.1111/j.1464-410X.1980.tb03067.x Toksu, 1971, Peyronie's disease: A method of treatment, J Urol, 105, 523, 10.1016/S0022-5347(17)61564-7 Furey, 1957, Peyronie's disease: Treatment by the local injection of meticortelone and hydrocortisone, J Urol, 77, 251, 10.1016/S0022-5347(17)66550-9 Cipollone, 1998, Betamethasone versus placebo in Peyronie's disease, Arch Ital Urol Androl, 70, 165 Jordan, 2008, The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: A prospective, single-center, non-placebocontrolled study, J Sex Med, 5, 180, 10.1111/j.1743-6109.2007.00651.x Levine, 1994, Intralesional verapamil injection for the treatment of Peyronie's disease, J Urol, 151, 1522, 10.1016/S0022-5347(17)35291-6 Levine, 1997, Treatment of Peyronie's disease with intralesional verapamil injection, J Urol, 158, 1395, 10.1016/S0022-5347(01)64224-1 Levine, 2002, Experience with intraplaque injection of verapamil for Peyronie's disease, J Urol, 168, 621, 10.1016/S0022-5347(05)64691-5 Anderson, 2000, Inhibition of Peyronie's plaque fibroblast proliferation by biologic agents, Int J Impot Res, 12, S25, 10.1038/sj.ijir.3900558 Rehman, 1998, Use of intralesional verapamil to dissolve Peyronie's disease plaque: A long-term single-blind study, Urology, 51, 620, 10.1016/S0090-4295(97)00700-0 Bennet, 2007, Intralesional verapamil prevents the progression of Peyronie's disease, J Urol, 69, 1181, 10.1016/j.urology.2007.02.042 Cavallini, 2007, Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease, Urology, 69, 950, 10.1016/j.urology.2007.01.080 Hellstrom, 2006, Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease, J Urol, 176, 394, 10.1016/S0022-5347(06)00517-9 Inal, 2006, Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: A randomized and prospective study, Urology, 67, 1038, 10.1016/j.urology.2005.11.005 Michel, 2003, Objective and subjective changes in patients with Peyronie's disease after management with shock wave therapy, J Endourol, 17, 41, 10.1089/089277903321196788 Strebel, 2004, Extracorporeal shock wave therapy for Peyronie's disease does not correct penile deformity, Int J Impot Res, 16, 448, 10.1038/sj.ijir.3901192 Hauck, 2004, Questionable efficacy of extracorporeal shock wave therapy in Peyronie's disease: Results of a prospective approach, J Urol, 171, 269 Hauck, 2004, Extracorporeal shock wave therapy for Peyronie's disease: Exploratory meta-analysis of clinical trials, J Urol, 171, 740, 10.1097/01.ju.0000108060.30363.8d Srirangam, 2006, Long-term results of extracorporeal shockwave therapy for Peyronie's disease, J Endourol, 20, 880, 10.1089/end.2006.20.880 Palmieri, 2009, A first prospective, randomized, double-blind, placebo- controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease, Eur Urol, 56, 363, 10.1016/j.eururo.2009.05.012 Riedl, 2000, Iontophoresis for treatment of Peyronie's disease, J Urol, 163, 95, 10.1016/S0022-5347(05)67981-5 Di Stasi, 2004, A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease, J Urol, 171, 1605, 10.1097/01.ju.0000116450.82816.2c Greenfield, 2007, Verapamil versus saline in electromotive drug administration for Peyronie's disease: A double-blind, placebo controlled trial, J Urol, 177, 972, 10.1016/j.juro.2006.10.065 Li, 2003, L-type calcium channels mediate mechanically induced bone formation in vivo, J Bone Miner Res, 18, 58 Alman, 1996, Regulation of proliferation and platelet-derived growth factor expression in palmar fibromatosis (Dupuytren contracture) by mechanical strain, J Orthop Res, 14, 722, 10.1002/jor.1100140507 Brighton, 1996, The biochemical pathway mediating the proliferative response of bone cells to a mechanical stimulus, J Bone Joint Surg Am, 78, 1337, 10.2106/00004623-199609000-00007 Levine, 2008, Penile traction therapy for treatment of Peyronie's disease: A single-center pilot study, J Sex Med, 5, 1468, 10.1111/j.1743-6109.2008.00814.x Gontero, 2009, Use of penile extender device in the treatment of penile curvature as a result of peyronie's disease. Results of a phase ii prospective study, J Sex Med, 6, 559, 10.1111/j.1743-6109.2008.01108.x Kendirci, 2004, Critical analysis of surgery for Peyronie's disease, Curr Opin Urol, 6, 381, 10.1097/00042307-200411000-00015 Taylor, 2008, Surgical correction of Peyronie's disease using Tunica albuginea plication or partial plaque excision with pericardial graft: Long-term followup, J Sex Med, 5, 2221, 10.1111/j.1743-6109.2008.00941.x Greenfield, 2006, Factors affecting the loss of length associated with tunical albuginea plication for correction of penile curvature, J Urol, 175, 238, 10.1016/S0022-5347(05)00063-7 Levine, 2007, Erectile dysfunction following surgical correction of Peyronie's disease and a pilot study of the use of Sildenafil citrate rehabilitation for postoperative erectile dysfunction, J Sex Med, 5, 241 Dimitriou, 1999, A surgical algorithm for penile prosthesis placement in men with erectile failure and Peyronie's Disease, J Urol, 161, 1014A Levine, 1997, A surgical algorithm for the treatment of Peyronie's disease, J Urol, 158, 2149, 10.1016/S0022-5347(01)68184-9 Mulhall, 2005, A surgical algorithm for men with combined Peyronie's disease and erectile dysfunction: Functional and satisfaction outcomes, J Sex Med, 2, 132, 10.1111/j.1743-6109.2005.20113.x Ralph, 2004, The management of Peyronie's disease, BJU Int, 93, 208, 10.1111/j.1464-410X.2004.04587.x Ralph, 1995, The Nesbit operation for Peyronie's disease: 16-year experience, J Urol, 4, 1362 Essed, 1985, New surgical technique for Peyronie's disease, Urology, 25, 582, 10.1016/0090-4295(85)90285-7 Yachia, 1990, Modified corporoplasty for the treatment of penile curvature, J Urol, 143, 80, 10.1016/S0022-5347(17)39871-3 Gholami, 2002, Correction of penile curvature using the 16-dot plication technique: A review of 132 patients, J Urol, 167, 2066, 10.1016/S0022-5347(05)65085-9 Bella, 2007, Minimally invasive intracorpal incision of peyronie's plaque. Peyronie's Disease, 241 Daitch, 1999, Modified corporoplasty for penile curvature: Long-term results and patient satisfaction, J Urol, 162, 2006, 10.1016/S0022-5347(05)68088-3 Rolle, 2005, The Nesbit operation for penile curvature: An easy and effective technical modification, J Urol, 173, 171, 10.1097/01.ju.0000147160.53124.1a Savoca, 2004, Straightening corporoplasty for Peyronie's disease: A review of 218 patients with median follow-up of 89 months, Eur Urol, 46, 610, 10.1016/j.eururo.2004.04.027 Syed, 2003, Nesbit procedure for disabling Peyronie's curvature: A median follow-up of 84 months, Urology, 61, 999, 10.1016/S0090-4295(02)02549-9 Dalkin, 1991, Venogenic impotence following dermal graft repair for Peyronie's disease, J Urol, 146, 849, 10.1016/S0022-5347(17)37941-7 Gelbard, 1995, Relaxing incisions in the correction of penile deformity due to Peyronie's disease, J Urol, 154, 1457, 10.1016/S0022-5347(01)66891-5 Kovac, 2007, Surgical outcomes and patient satisfaction after dermal, pericardial, and small intestinal submucosal grafting for Peyronie's disease, J Sex Med, 4, 1500, 10.1111/j.1743-6109.2007.00453.x Leungwattanakij, 2001, Long-term follow-up on use of pericardial graft in the surgical management of Peyronie's disease, Int J Impot Res, 13, 183, 10.1038/sj.ijir.3900676 Choi, 2008, Erectile dysfunction after plaque incision and grafting: Incidence and predictors, 10.1016/S0022-5347(08)60738-7 Kadioglu, 2007, Graft materials in Peyronie's disease surgery: A comprehensive review, J Sex Med, 4, 581, 10.1111/j.1743-6109.2007.00461.x Brannigan, 1998, Comparison of tunica albuginea substitute for the treatment of Peyronie's disease, J Urol, 159, 1064, 10.1016/S0022-5347(01)63836-9 Edygio, 2002, Treatment of Peyronie's disease by incomplete circumferential incession of the tunica albuginea and plaque with bovine pericardium graft, Urology, 59, 570, 10.1016/S0090-4295(01)01651-X Moncata-Iribarren, 2007, Managing penile shortening after Peyronie's disease surgery: A comprehensive review, J Sex Med, 177, 252 Knoll, 2007, Use of small intestinal submucosa graft for the surgical management of Peyronie's disease, J Urol, 178, 2474, 10.1016/j.juro.2007.08.044 Hatzichristou, 2002, Corporoplasty using tunica albuginea free grafts of penile curvature: Surgical technique and longterm results, J Urol, 167, 1367, 10.1016/S0022-5347(05)65302-5 Lue, 1998, Venous patch graft for Peyronie's disease. Part I: Technique, J Urol, 160, 2047, 10.1016/S0022-5347(01)62239-0 Levine, 2003, Human cadaveric pericardial graft for the surgical correction of Peyronie's disease, J Urol, 170, 2359, 10.1097/01.ju.0000091102.10849.95 Breyer, 2007, Complications of porcine small intestine submucosa graft for Peyronie's disease, J Urol, 177, 589, 10.1016/j.juro.2006.09.051 Hsu, 2007, Long-term results of autologous venous grafts for penile morphological reconstruction, J Androl, 28, 186, 10.2164/jandrol.106.000760 Kalsi, 2005, The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie's disease, BJU Int, 95, 1029, 10.1111/j.1464-410X.2005.05459.x Montorsi, 2004, Five year follow up of plaque incision and vein grafting for Peyronie's disease, 10.1016/S1569-9056(04)90125-X Wilson, 1994, Delk 2nd JR. A new treatment for Peyronie's disease: Modeling the penis over an inflatable penile prothesis, J Urol, 152, 1121, 10.1016/S0022-5347(17)32519-3